title: Novel role of the membrane-bound chemokine fractalkine in platelet activation and adhesion.
abstract: Chemokines released by the endothelium have proaggregatory properties on platelets. Fractalkine, a recently discovered membrane-bound chemokine with a transmembrane domain, is expressed in vascular injury; however, the effects of fractalkine on platelets have not yet been investigated. Blood was taken from healthy Wistar-Kyoto rats and the expression of the fractalkine receptor on platelets was demonstrated. The modulation of surface expression of P-selectin was assessed by flow cytometry. P-selectin expression was significantly enhanced by in vitro stimulation with recombinant rat fractalkine compared with baseline levels. Selectively inhibiting the function of recombinant fractalkine by an antagonizing antibody or the disruption of the G-protein-coupled intracellular signaling cascade of the fractalkine receptor by pertussis toxin (PTX) completely prevented fractalkine-mediated platelet activation. Preincubation with apyrase significantly attenuated the fractalkine-induced degranulation. In a flow chamber model of platelet adhesion, stimulation with fractalkine significantly enhanced platelet adhesion to collagen and fibrinogen. Similar to P-selectin expression, enhanced adhesion could be prevented by the antagonizing antibody or preincubation of platelets with PTX. Fractalkine, which is overexpressed in atherosclerosis and vascular injury, contributes to platelet activation and adhesion and hence is likely to play a pathophysiologically important role for increased thrombogenesis in vascular diseases.
authors.affiliation: Medizinische Universitätsklinik Würzburg, Josef-Schneider-Str 2, 97080 Würzburg, Germany. a.schaefer@medizin.uniwuerzburg.de
authors.forename: Andreas
authors.initials: A
authors.lastname: Schäfer
authors.forename: Christian
authors.initials: C
authors.lastname: Schulz
authors.forename: Martin
authors.initials: M
authors.lastname: Eigenthaler
authors.forename: Daniela
authors.initials: D
authors.lastname: Fraccarollo
authors.forename: Anna
authors.initials: A
authors.lastname: Kobsar
authors.forename: Meinrad
authors.initials: M
authors.lastname: Gawaz
authors.forename: Georg
authors.initials: G
authors.lastname: Ertl
authors.forename: Ulrich
authors.initials: U
authors.lastname: Walter
authors.forename: Johann
authors.initials: J
authors.lastname: Bauersachs
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001792:Blood Platelets / Q000276:immunology*; D000073883:CX3C Chemokine Receptor 1; D054428:Chemokine CX3CL1; D020523:Chemokines, CX3C / Q000097:blood*; D005340:Fibrinogen / Q000502:physiology; D005434:Flow Cytometry; D015498:HIV-2; D006801:Humans; D066298:In Vitro Techniques; D008565:Membrane Proteins / Q000097:blood*; D019007:P-Selectin / Q000097:blood; D015539:Platelet Activation; D010973:Platelet Adhesiveness; D051381:Rats; D017208:Rats, Wistar; D018121:Receptors, Cytokine / Q000097:blood; D015728:Receptors, HIV / Q000097:blood
chemical_list: D000073883:CX3C Chemokine Receptor 1; C515538:CX3CL1 protein, human; D054428:Chemokine CX3CL1; D020523:Chemokines, CX3C; C515540:Cx3cl1 protein, rat; D008565:Membrane Proteins; D019007:P-Selectin; D018121:Receptors, Cytokine; D015728:Receptors, HIV; D005340:Fibrinogen